Tetrahydropalmatine Uses, Dosage, Side Effects and more
Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).
| Attribute | Details |
|---|---|
| Trade Name | Tetrahydropalmatine |
| Generic | Tetrahydropalmatine |
| Type | |
| Formula | C21H25NO4 |
| Weight | Average: 355.434 Monoisotopic: 355.178358289 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
